Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Bora Pharmaceuticals

Tracked across 3 events · 20 articles · First seen May 12, 2026 · Last active Sep 01, 2026

Sentiment
53
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Bora Pharmaceuticals is acquiring the GMP manufacturing operations of MacroGenics, Inc. for US$122.5 million, strengthening its biologics CDMO platform in the United States.
May 12, 2026 · 6 articles
4 75
Business
Impact: Bora Pharmaceuticals completed the acquisition of MacroGenics' manufacturing operations, expanding its biologics CDMO capabilities and establishing a significant US manufacturing platform. This strengthens its position in the pharmaceutical services industry.
Jul 02, 2026 · 7 articles
2 15
Regulatory
Impact: Bora Pharmaceuticals, the licensor of TAVALISSE, may benefit from increased sales and royalties as Knight expands the drug's availability in Latin America.
Sep 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Bora Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.